Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

New study shows declines in prostate cancer screening, diagnoses and treatment

A new study reveals declines in prostate cancer screening and diagnoses in the United States in recent years, as well as decreases in the use of definitive treatments in men who have been diagnosed.

21 May 2018

Unique nanotechnology method to simplify skin disease diagnosis

In a new SLAS Technology auto-commentary, two authors of an article recently published in Nature Biomedical Engineering ("Abnormal Scar Identification with Spherical Nucleic Acid Technology" – www.nature.com/articles/s41551-018-0218-x) share more insight into their unique method for skin disease diagnosis using NanoFlare nanotechnology.

21 May 2018

Researcher aims to develop virtual biopsy tool for early melanoma detection

With Skin Cancer Awareness Month upon us, Colorado State University researcher Jesse Wilson is accelerating research to improve imaging and detection of melanoma, the most deadly form of skin cancer, and the fifth most common cancer in the United States.

21 May 2018

Researchers use MR spectroscopy to investigate mechanisms behind targeted treatment for gliomas

Using a novel imaging method, a Massachusetts General Hospital research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas.

21 May 2018

New blood test could help avoid more than 40% of prostate biopsies, study finds

A multi-center study that validates the clinical performance of IsoPSA - a new blood test that has proven to be more accurate in predicting overall risk of prostate cancer than standard prostate-specific antigen - will be presented during a special press conference at the 13th Annual Meeting of the American Urological Association on May 18 in San Francisco.

18 May 2018

VA health care study: Many prostate cancer patients choose active surveillance over immediate therapy

Record numbers of American veterans diagnosed with non-aggressive prostate cancer are heeding the advice of international medical experts and opting out of immediate surgery or radiation to treat their cancer.

16 May 2018

Study: MRI fusion biopsy outperforms standard prostate biopsy

Researchers at the University of Cincinnati have found that MRI fusion biopsy--coupling MRI and ultrasound to visualize suspicious lesions in the prostate gland and targeting the biopsy to that particular area--outperformed standard prostate biopsy in patients with a prior negative prostate biopsy.

16 May 2018

Centrosome amplification may contribute to initiation of cancers, research suggests

Cells begin to accumulate centrosomes-;organelles that play a vital role during cell division-;before they transform into cancer cells, according to a new study of patients with Barrett's esophagus condition, which is associated with esophageal cancer.

8 May 2018

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

Neon Therapeutics, a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it has treated the first patient in a clinical trial evaluating its proprietary personal neoantigen vaccine, NEO-PV-01, in combination with Merck's anti-PD-1 therapy, KEYTRUDA®, along with chemotherapy.

8 May 2018

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

Today physicians are still severely hampered by the lack of precision of the needle tip location during a biopsy. Looking at lung cancers, 25% of the diagnoses suffer a false negative outcome through traditional biopsy methods. In the future, this can be avoided: for the first time, the European project InSPECT developed miniature spectrometers with integrated light sources enabling guided sensing.

8 May 2018

Novel 3D cancer model to accelerate development of new and better treatments

A scientist at the University of Virginia School of Medicine, working with local biotech company HemoShear Therapeutics, has created a three-dimensional model of a cancer tumor that he says has the potential to replicate the complex nature and behavior of a real tumor.

7 May 2018

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform sentinel lymph node biopsy (SLNB) recommendations.

7 May 2018

Researchers discover how a light touch can lead to unbearable itching

For some people, particularly those who are elderly, even a light touch of the skin or contact with clothing can lead to unbearable itching.

4 May 2018

Penn surgeons perform first ever robot-assisted complex spinal surgery for rare tumor removal

Noah Pernikoff is back to his life in New York City after becoming the first patient in the world to undergo a complex three-part, robotic-assisted surgery.

3 May 2018

Moving beyond traditional 'magic bullet' approach for discovering new drugs

It's time to move beyond the traditional 'magic bullet' approach for discovering new drugs and start leveraging the full complexity of Mother Nature, say Vanderbilt Professor of Chemistry Brian Bachmann and Assistant Professor of Cell and Developmental Biology Jonathan Irish.

3 May 2018

Nearly 50 people present with rare eye cancer - ocular melanoma

At least 50 people have been diagnosed with a rare type of eye cancer called ocular melanoma. They are all residents of two locations - Huntersville, North Carolina, and Auburn, Alabama. The cancer is rare and occurs in only six per 1 million population. The high rate of incidence of this cancer in these two locations has stumped researchers.

2 May 2018

Biopsy News and Research

Further Reading

New study shows declines in prostate cancer screening, diagnoses and treatment

Unique nanotechnology method to simplify skin disease diagnosis

Researcher aims to develop virtual biopsy tool for early melanoma detection

Researchers use MR spectroscopy to investigate mechanisms behind targeted treatment for gliomas

New blood test could help avoid more than 40% of prostate biopsies, study finds

VA health care study: Many prostate cancer patients choose active surveillance over immediate therapy

Study: MRI fusion biopsy outperforms standard prostate biopsy

Centrosome amplification may contribute to initiation of cancers, research suggests

Neon Therapeutics evaluates safety, efficacy of NEO-PV-01 in combination with KEYTRUDA and chemotherapy

European project InSPECT develops miniature photonics spectrometers for tissue diagnostics

Novel 3D cancer model to accelerate development of new and better treatments

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Researchers discover how a light touch can lead to unbearable itching

Penn surgeons perform first ever robot-assisted complex spinal surgery for rare tumor removal

Moving beyond traditional 'magic bullet' approach for discovering new drugs

Nearly 50 people present with rare eye cancer - ocular melanoma

Novel magnetic nanoparticles move from lab to first breast cancer clinical trials

Samsung RS85 ultrasound system receives FDA 510(k) clearance

Blood biopsies may offer more comprehensive genetic information than bone marrow tests, shows research

New noninvasive technique uses blood test to detect brain tumor biomarkers

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News